Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Radiology|January 26, 2018
Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H MutationZachary K Englander, Craig I Horenstein, Stephen G Bowden, et al.
International Journal of Oral and Maxillofacial Surgery|November 23, 2023
Placing the maxilla in the most aesthetic sagittal position: validation of several reference lines in relation to the forehead shapeM W J Chen, J L Lum, C W Yong, et al.
DICP : the Annals of Pharmacotherapy|February 1, 1989
A clinical pharmacy-oriented drug surveillance network: results of a nationwide antibiotic utilization review of bacterial pneumonia--1987T H Grasela, J J Schentag, S J Boekenoogen, et al.
Pathogens and Global Health|September 5, 2012
Reviewing the development, evidence base, and application of the revised dengue case classificationO Horstick, J Farrar, L Lum, et al.
Pediatric Transplantation|July 30, 2020
Time to second kidney transplantation in young adults after failed pediatric kidney transplantKorntip Phonphok, Piyavadee Homkrailas, Tin Duong, et al.
Disability and Rehabilitation|April 1, 1994
Disease, impairment, disability and social handicap: a community based study of people aged 70 years and overA J Campbell, W J Busby, M C Robertson, et al.
The Journal of Biological Chemistry|March 28, 1998
Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cellsD Inoue, M Reid, L Lum, et al.
BMC Nephrology|August 22, 2018
PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin - case reportJonathan W Goldman, Basmah Abdalla, Melody A Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2001
Long-term results of irradiation for patients with progressive Graves' ophthalmopathyS D Marquez, B L Lum, I R McDougall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2005
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistanceR Advani, B L Lum, G A Fisher, et al.
Pageof 18